| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Unit on Genetics and Endocrinology, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (F.S., C.F., L.S.K., C.A.S.), Bethesda, Maryland 20892; Departments of Pediatrics, Cell Biology, and Biochemistry and Molecular Biology, Georgetown University (S.-M.W., W.-Y.C.), Washington, D.C. 20007; Unité de Recherches sur les Handicaps Génétiques de lEnfant, INSERM, U-393, Departement de Génétique, Hôpital Necker-Enfants Malades (A.T.-P., S.L.), 75743 Paris Cedex 15, France; Endocrinology and Diabetes Unit, British Columbias Childrens Hospital (D.L.M.), Vancouver, BC V6H 3V4, Canada; Department of Pediatrics, Childrens Hospital (C.J.B.), San Juan PR00907, Puerto Rico; and Department of Pediatrics, Rambam Medical Center (D.T.), Haifa, 31096 Israel
Address all correspondence and requests for reprints to: Constantine A. Stratakis, M.D., D.Sc., Unit on Genetics and Endocrinology, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive, MSC1862, Bethesda, Maryland 20892. E-mail: stratakc{at}cc1.nichd.nih.gov
Abstract
Familial glucocorticoid deficiency due to corticotropin (ACTH)
resistance consists of two distinct genetic syndromes that are both
inherited as autosomal recessive traits: isolated ACTH resistance
(iACTHR), which may be caused by inactivating mutations of the ACTH
receptor (the MC2R gene) or mutations in an as yet unknown gene(s), and
Allgrove syndrome (AS). The latter is also known as triple-A syndrome
(MIM 231550). In three large cohorts of AS kindreds, the disease has
been mapped to chromosome 12; most recently, mutations in the
AAAS gene on 12q13 were found in these AS families.
AAAS codes for the WD-repeat containing ALADIN (for
alacrima-achalasia-adrenal insufficiency-neurologic disorder) protein.
We investigated families with iACTHR (n = 4) and AS (n = 6)
and a Bedouin family with ACTHR and a known defect of the TSH receptor.
Four AS families were of mixed extraction from Puerto Rico (PR); most
of the remaining six families were Caucasian families from North
America (NA). Sequencing analysis found no MC2R genetic
defects in any of the kindreds. No iACTHR kindreds, but all of AS
families, had AAAS mutations. The previously reported
IVS14+1G
A splice donor mutation was found in all PR families,
apparently due to a founder effect; one NA kindred was heterozygous for
this mutation. In the latter family, long-range PCR failed to identify
a deletion or other rearrangements of the AAAS gene. No
other heterozygote or transmitting parent had any phenotype that could
be considered part of AS. The IVS14+1G
A mutation results in a
premature termination of the predicted protein; although it was present
in all PR families (in the homozygote state in three of them), there
was substantial clinical variation between them. One PR family also
carried a novel splice donor mutation of the AAAS gene
in exon 11, IVS11+1G
A; the proband was a compound heterozygote. A
novel point mutation, 43C
A(Gln15Lys), in exon 1 of the
AAAS gene was identified in the homozygote state in a
Canadian AS kindred with a milder AS phenotype. The predicted amino
acid substitution in this family is located in a sequence that may
participate in the preservation of stability of ALADIN ß-strands,
whereas the splicing mutation in exon 11 may interfere with the
formation of WD repeats in this molecule. We conclude that 1)
AAAS does not appear to be frequently mutated in
families with iACTHR; 2) AAAS is mutated in AS families
from PR (that had previously been mapped to 12q13) and NA; and, 3)
there is significant clinical variability between patients with the
same AAAS defect.
This article has been cited by other articles:
![]() |
R. A. Artigas, A. Gonzalez, E. Riquelme, C. A. Carvajal, A. Cattani, A. Martinez-Aguayo, A. M. Kalergis, T. Perez-Acle, and C. E. Fardella A Novel Adrenocorticotropin Receptor Mutation Alters Its Structure and Function, Causing Familial Glucocorticoid Deficiency J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3097 - 3105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. A. Collares, J. Antunes-Rodrigues, A. C. Moreira, S. N. Franca, L. A. Pereira, M. M. S. Soares, J. Elias Junior, A. J Clark, M. de Castro, and L. L. K. Elias Heterogeneity in the molecular basis of ACTH resistance syndrome. Eur. J. Endocrinol., July 1, 2008; 159(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Axelrod, G. G. Chelimsky, and D. E. Weese-Mayer Pediatric Autonomic Disorders Pediatrics, July 1, 2006; 118(1): 309 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirano, Y. Furiya, H. Asai, A. Yasui, and S. Ueno ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome PNAS, February 14, 2006; 103(7): 2298 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Cronshaw and M. J. Matunis The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome PNAS, May 13, 2003; 100(10): 5823 - 5827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tiosano, I. Eisentein, D. Militianu, G. P. Chrousos, and Z.'e. Hochberg 11{beta}-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Houlden, S. Smith, M. de Carvalho, J. Blake, C. Mathias, N. W. Wood, and M. M. Reilly Clinical and genetic characterization of families with triple A (Allgrove) syndrome Brain, December 1, 2002; 125(12): 2681 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Cronshaw, A. N. Krutchinsky, W. Zhang, B. T. Chait, and M. J. Matunis Proteomic analysis of the mammalian nuclear pore complex J. Cell Biol., September 3, 2002; 158(5): 915 - 927. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |